Filter Results:
(585)
Show Results For
- All HBS Web
(4,586)
- Faculty Publications (585)
Show Results For
- All HBS Web
(4,586)
- Faculty Publications (585)
- November 2010
- Article
Stress-Test Your Strategy: The 7 Questions to Ask
By: Robert Simons
An economic downturn can quickly expose the shortcomings of your business strategy. But can you identify its weak points in good times as well? And can you focus on those weak points that really matter? I identify seven questions all executives should ask in order to... View Details
Keywords: Business Strategy; Creativity; Success; Customers; Employees; Business and Shareholder Relations; Performance; Risk and Uncertainty; Decision Choices and Conditions
Simons, Robert. "Stress-Test Your Strategy: The 7 Questions to Ask." Harvard Business Review 88, no. 11 (November 2010): 93–100.
- October 2010 (Revised July 2011)
- Case
PrimedicProviding Primary Care in Mexico
By: Richard G. Hamermesh, Regina Garcia-Cuellar and Lauren Sarah Margulies
Primedic is a Mexican start-up that aims to deliver affordable primary and preventative healthcare to those at the base of the economic pyramid. The company is about to exhaust its first round of venture capital funding and the business model has yet to gain traction.... View Details
Keywords: Business Model; Business Startups; Developing Countries and Economies; Social Entrepreneurship; Venture Capital; Health Care and Treatment; Social Enterprise; Health Industry; Mexico
Hamermesh, Richard G., Regina Garcia-Cuellar, and Lauren Sarah Margulies. "PrimedicProviding Primary Care in Mexico." Harvard Business School Case 811-040, October 2010. (Revised July 2011.)
- September 2010 (Revised November 2011)
- Case
Salud Digna: Successfully Competing with For-Profit Organizations
By: Allen S. Grossman and Regina Garcia-Cuellar
Hugo Moreno, CEO of Salud Digna, was considering his growth options for the next three years. Would becoming a for-profit with access to greater capital be the best strategy or would this cause the organization to lose its social mission? Salud Digna provided... View Details
Keywords: For-Profit Firms; Health Testing and Trials; Growth and Development Strategy; Corporate Social Responsibility and Impact; Mission and Purpose; Nonprofit Organizations; Health Industry; Mexico
Grossman, Allen S., and Regina Garcia-Cuellar. "Salud Digna: Successfully Competing with For-Profit Organizations." Harvard Business School Case 311-051, September 2010. (Revised November 2011.)
- August 2010 (Revised December 2010)
- Supplement
Urban Water Partners (A) (CW)
By: Karthik Ramanna and George Serafeim
The case explores a new venture to bring clean water to Tanzanians who otherwise cannot access or afford it. Management has enough money to get their company through August 2010, but needs more capital. An HBS alum is interested in investing in the company;... View Details
- August 2010 (Revised January 2013)
- Supplement
Urban Water Partners (B)
By: Karthik Ramanna, George Serafeim and Aldo Sesia
The case explores a new business venture to bring clean water to residents of Dar es Salaam, Tanzania, who otherwise cannot afford it. Management has enough money to get their company through August 2010, but needs more capital thereafter. An HBS alumnus is interested... View Details
Keywords: Human Needs; Accrual Accounting; Financial Statements; Health Industry; Health Industry; Dar es Salaam
Ramanna, Karthik, George Serafeim, and Aldo Sesia. "Urban Water Partners (B)." Harvard Business School Supplement 111-029, August 2010. (Revised January 2013.)
- August 2010 (Revised March 2012)
- Case
The UCLA Medical Center: Kidney Transplantation
By: Michael E. Porter, Jennifer F Baron, Jacob Mathew Chacko and Robin Jian Tang
In 2010, organ transplantation remained among the few sets of medical conditions in the U.S. for which bundled payments were a dominant reimbursement model, and for which patient health outcomes were universally measured and reported. In 1986, UCLA Medical Center was... View Details
Keywords: Insurance; Health Care and Treatment; Health Disorders; Measurement and Metrics; Outcome or Result; Competitive Strategy; Integration; Health Industry; California
Porter, Michael E., Jennifer F Baron, Jacob Mathew Chacko, and Robin Jian Tang. "The UCLA Medical Center: Kidney Transplantation." Harvard Business School Case 711-410, August 2010. (Revised March 2012.)
- June 2010
- Article
Quality Management and Job Quality: How the ISO 9001 Standard for Quality Management Systems Affects Employees and Employers
By: David I. Levine and Michael W. Toffel
Several studies have examined how the ISO 9001 Quality Management System standard predicts changes in organizational outcomes such as profits. This is the first large-scale study to explore how employee outcomes such as employment, earnings, and health and safety... View Details
Keywords: Quality; Management; Standards; Employees; Wages; Organizations; Profit; Safety; Health; Policy
Levine, David I., and Michael W. Toffel. "Quality Management and Job Quality: How the ISO 9001 Standard for Quality Management Systems Affects Employees and Employers." Management Science 56, no. 6 (June 2010): 978–996. (Appendix. Profiled by industry practitioners in Quality Digest, Quality Progress, ANSI-ASQ National Accreditation Board (ANAB).)
- April 2010 (Revised January 2013)
- Case
California's Budget Crises, Tax Reform, and Domestic and International Tax Competition
By: Matthew C. Weinzierl and Jacob Kuipers
How do (and how should) governments design fiscal policies to compete in a globalized economy while meeting internal policy priorities including redistribution? In 2009, Governor Arnold Schwarzenegger repeatedly declared fiscal emergencies as California's state budget... View Details
Keywords: Budgets and Budgeting; Economy; Globalization; Governing Rules, Regulations, and Reforms; Policy; Taxation; Competition; California
Weinzierl, Matthew C., and Jacob Kuipers. "California's Budget Crises, Tax Reform, and Domestic and International Tax Competition." Harvard Business School Case 710-038, April 2010. (Revised January 2013.)
- March 2010 (Revised April 2014)
- Case
American Well: The Doctor Will E-See You Now
By: Elie Ofek and Ron Laufer
What is next for healthcare IT provider American Well, whose innovative Online Care technology allows physicians to deliver care to patients online in real time? Using American Well's platform, patients with non-emergency health concerns can communicate with physicians... View Details
Keywords: Entrepreneurship; Health Care and Treatment; Technological Innovation; Growth and Development Strategy; Market Entry and Exit; Service Delivery; Online Technology; Health Industry
Ofek, Elie, and Ron Laufer. "American Well: The Doctor Will E-See You Now." Harvard Business School Case 510-061, March 2010. (Revised April 2014.)
- February 2010 (Revised November 2012)
- Case
Indus Towers: Collaborating with Competitors on Infrastructure
By: Ranjay Gulati, Francisco de Asis Martinez-Jerez, V.G. Narayanan and Rachna Tahilyani
The case describes the formation of Indus Towers, the largest telecom tower company in the world that has a joint venture created to build and manage the passive infrastructure of wireless telecom operators by bringing together three competitors in India's tough... View Details
Keywords: Joint Ventures; Cost Management; Infrastructure; Alliances; Competition; Cooperation; Telecommunications Industry; India
Gulati, Ranjay, Francisco de Asis Martinez-Jerez, V.G. Narayanan, and Rachna Tahilyani. "Indus Towers: Collaborating with Competitors on Infrastructure." Harvard Business School Case 110-057, February 2010. (Revised November 2012.)
- December 2009 (Revised September 2024)
- Case
Phreesia: The Patient Intake Company
How should the co-founders of an organization that provides patient sign-in and billing services scale their company after five years of successfully targeting small private physician practices? Phreesia had deployed a direct mail and sales force strategy that resulted... View Details
Herzlinger, Regina E. "Phreesia: The Patient Intake Company." Harvard Business School Case 310-066, December 2009. (Revised September 2024.)
- November 2009 (Revised August 2010)
- Case
NovoCure Ltd.
By: William A. Sahlman and Sarah Flaherty
Venture capitalist William Doyle must raise $35 million for a portfolio company with a promising, novel cancer therapy, just as global capital markets are imploding in the fall of 2008. NovoCure, Ltd., has developed an electrical-field-based therapy, called Tumor... View Details
Keywords: Financial Crisis; Entrepreneurship; Venture Capital; Investment; Health Care and Treatment; Health Testing and Trials; Technological Innovation; Financial Services Industry
Sahlman, William A., and Sarah Flaherty. "NovoCure Ltd." Harvard Business School Case 810-045, November 2009. (Revised August 2010.)
- November 2009 (Revised December 2009)
- Case
GTC Biotherapeutics: Developing Medicines in the Milk of Goats
By: Ray A. Goldberg and Sarah Morton
GTC is the first company in the animal world to receive FDA approval of a transgenic pharmaceutical. What are the implications for other firms in plants and animals and their opportunities to produce new medicines in an economical and safe fashion? View Details
Keywords: Health Care and Treatment; Animal-Based Agribusiness; Plant-Based Agribusiness; Science-Based Business; Medical Specialties; Product; Technological Innovation; Health Industry; Health Industry; United States
Goldberg, Ray A., and Sarah Morton. "GTC Biotherapeutics: Developing Medicines in the Milk of Goats." Harvard Business School Case 910-403, November 2009. (Revised December 2009.)
- 2009
- Book
Merchants to Multinationals
By: G. Jones
Merchants to Multinationals examines the evolution of multinational trading companies from the eighteenth century to the present day. During the Industrial Revolution, British merchants established overseas branches which became major trade intermediaries and... View Details
- October 2009 (Revised August 2014)
- Case
Tengion: Bringing Regenerative Medicine to Life
By: Elie Ofek and Polly Ross Ribatt
Tengion is a young biotech company that is at the frontier of regenerative medicine—a nascent field that seeks to promote the creation of new cells and tissue to repair or replace tissue or organ function lost due to age, disease, damage, or congenital defects. In late... View Details
Keywords: Decision Choices and Conditions; Financial Crisis; Entrepreneurship; Health Care and Treatment; Technological Innovation; Product Launch; Product Development; Research and Development; Biotechnology Industry; United States
Ofek, Elie, and Polly Ross Ribatt. "Tengion: Bringing Regenerative Medicine to Life." Harvard Business School Case 510-031, October 2009. (Revised August 2014.)
- 2009
- Working Paper
Operational Failures and Problem Solving: An Empirical Study of Incident Reporting
By: Julia Rose Adler-Milstein, Sara J. Singer and Michael W. Toffel
Operational failures occur in all industries with consequences that range from minor inconveniences to major catastrophes. Many organizations have implemented incident reporting systems to highlight actual and potential operational failures in order to encourage... View Details
Keywords: Communication Strategy; Legal Liability; Management Practices and Processes; Service Operations; Failure; Health Industry
Adler-Milstein, Julia Rose, Sara J. Singer, and Michael W. Toffel. "Operational Failures and Problem Solving: An Empirical Study of Incident Reporting." Harvard Business School Working Paper, No. 10-017, September 2009. (August 2009.)
- August 2009
- Case
Intel NBI: Vivonic
By: Willy C. Shih and Thomas Thurston
Vivonic was a start-up that was part of Intel's New Business Initiatives that sought to develop and sell personal health monitoring hardware and software. When it was first funded, Intel was in the midst of record growth and was seeking diversification. But the company... View Details
Keywords: Business Startups; Experience and Expertise; Corporate Entrepreneurship; Product Development; Failure; Diversification; Semiconductor Industry
Shih, Willy C., and Thomas Thurston. "Intel NBI: Vivonic." Harvard Business School Case 610-025, August 2009.
- 2009
- Chapter
Evaluating the Impact of SA8000 Certification
By: Michael J. Hiscox, Claire Schwartz and Michael W. Toffel
SA 8000, along with other types of certification standards and corporate codes of conduct, represents a new form of private governance of working conditions, initiated and implemented by companies, labor unions, and non-governmental activist groups. Whether these codes... View Details
Hiscox, Michael J., Claire Schwartz, and Michael W. Toffel. "Evaluating the Impact of SA8000 Certification." In Social Accountability 8000: The First Decade -- Implementation, Influence, and Impact, edited by Deborah Leipziger. Greenleaf Publishing, 2009.
- March 2009 (Revised September 2010)
- Case
Dartmouth-Hitchcock Medical Center: Spine Care
By: Robert S. Huckman, Michael E. Porter, Rachel Gordon and Natalie Kindred
Describes the Spine Center at Dartmouth-Hitchcock Medical Center, a multidisciplinary unit that offers patients suffering from spinal problems "one-stop" access to a range of providers including orthopedic surgeons, neurosurgeons, neurologists, medical specialists in... View Details
Keywords: Health Care and Treatment; Medical Specialties; Service Delivery; Service Operations; Integration; Value Creation; Health Industry; United States
Huckman, Robert S., Michael E. Porter, Rachel Gordon, and Natalie Kindred. "Dartmouth-Hitchcock Medical Center: Spine Care." Harvard Business School Case 609-016, March 2009. (Revised September 2010.)
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)